Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Late 2nd dose.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (on 23-JUN-2021 received 1st dose). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Late 2nd dose.). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 24-FEB-2025 The patient got the first dose of Shingrix and had not gotten the 2nd one yet. Till the time of reporting the patient had not received the second dose of Shingrix, which led to incomplete course of vaccination.